Recall of the Stryker Rejuvenate and ABG II Modular-Neck Stems

In July 2012, Stryker posted a notice on its website that it was issuing a voluntary Stryker hip replacement recall of its Rejuvenate Modular and ABG II modular-neck hip stem systems. According to the notice, the recalled implants were associated with fretting and/or corrosion at the neck junction, which may result in pain and/or swelling. This could lead to adverse local tissue reactions, or metallosis. Such a reaction could result in soft tissue necrosis, muscle injury, pseudotumor formation and premature failure of the hip implant.

These problems first came to light in April 2012, when Stryker issued an Urgent Safety Alert to warn surgeons that Stryker Rejuvenate Modular Hip Systems had been related to corrosion and other problems at the modular sites. Then, on May 28, 2012, it was announced that Stryker Rejuvenate was being recalled in Canada so the instructions for use could be updated.

According to the company’s Stryker hip replacement recall notice, patients with the recalled devices should seek the advice of their surgeons if they experience unexplained swelling or pain at the joint where their hip replacement surgery was performed. Patients who have not experienced any symptoms should follow the post-operative plan outlined by their surgeon.

If you or someone you love suffered a Stryker hip replacement recall failure, metallosis or other injury that could be related to Stryker’s Rejuvenate and ABG II modular-neck stem hip implant systems, the Stryker hip replacement lawyers at Carabin Shaw would like to talk with you. For a free Stryker hip replacement lawsuit evaluation, please fill out our online form, or call 800-862-1260.